MDM2 and P53 polymorphisms contribute together to the risk and survival of prostate cancer
about
Relationships between cell cycle pathway gene polymorphisms and risk of hepatocellular carcinomaMurine Double Minute 2 SNP T309G Polymorphism and Urinary Tract Cancer Risk: A Meta-AnalysisMolecular mechanisms involving prostate cancer racial disparity.Targeting the NFAT1-MDM2-MDMX Network Inhibits the Proliferation and Invasion of Prostate Cancer Cells, Independent of p53 and Androgen.Immunogenetics of prostate cancer: a still unexplored field of study.
P2860
MDM2 and P53 polymorphisms contribute together to the risk and survival of prostate cancer
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 May 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MDM2 and P53 polymorphisms con ...... nd survival of prostate cancer
@en
MDM2 and P53 polymorphisms con ...... d survival of prostate cancer.
@nl
type
label
MDM2 and P53 polymorphisms con ...... nd survival of prostate cancer
@en
MDM2 and P53 polymorphisms con ...... d survival of prostate cancer.
@nl
prefLabel
MDM2 and P53 polymorphisms con ...... nd survival of prostate cancer
@en
MDM2 and P53 polymorphisms con ...... d survival of prostate cancer.
@nl
P2093
P2860
P356
P1433
P1476
MDM2 and P53 polymorphisms con ...... nd survival of prostate cancer
@en
P2093
Hecheng Li
Peng Zhang
Rongrong Liu
Xiujuan Han
Zhenlong Wang
Ziming Wang
P2860
P304
31825-31831
P356
10.18632/ONCOTARGET.3923
P407
P577
2015-05-18T00:00:00Z